Dr. Douglas Yee, MD

Dr. Yee practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Yee's NPI, 1598851198, was assigned on October 4, 2006. Dr. Yee graduated from Pritzker School of Medicine in 1981. Dr. Yee holds Minnesota license 41547.

Dr. Yee's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Yee's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Yee is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Yee to 1 more hospital, 1 dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yee practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Yee's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Yee is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Yee's licenses on file in 3 states: Minnesota, Texas and North Carolina.

CMS data shows 80 Medicare services from Dr. Yee across 2 procedure codes in 2024, for 41 Medicare patients. Medicare paid $3,354 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 41 Medicare patients who saw Dr. Yee in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have cancer, and 68% have high cholesterol. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yee's median patient age at 63, with 98% women.

In 2024, Dr. Yee wrote 110 Medicare Part D claims for 32 patients. 89% of them were for generic drugs. CMS names the drug for 43 of them, across 2 drugs with 11 or more claims each, at $946 in total drug cost. In 2023, CMS named 45 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Yee for performance year 2024, reported as part of a group. Dr. Yee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yee as offering telehealth.

Dmand AI links 219 papers to Dr. Yee, published from 2000 to 2024. 2016 was the busiest year, with 11. The most frequent topics are Breast Neoplasms, Insulin-Like Growth Factor I and Signal Transduction. Dr. Yee has published most often in Breast Cancer Res Treat. Dr. Yee's most frequent co-authors are Laura J. Esserman, MD, Angela Demichele, MD and Hope S. Rugo, MD.

Dmand AI links Dr. Yee to 6 clinical trials, 4 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Pathologic Complete Response. Masonic Cancer Center, University of Minnesota sponsors the most, 3.

CMS Open Payments shows 19 general payments to Dr. Yee from 8 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 46% of the total. Boehringer Ingelheim Pharma GmbH & Co.KG paid the most, $3,655. It also lists 4 research payments totaling $4,793 in 2016.

Dmand AI lists 2 awards for Dr. Yee, most recently CMS Stage 1 EHR in 2013.

Dr. Yee graduated from Pritzker School of Medicine in 1981. Dr. Yee is a member of ASCO.

Dr. Yee is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.